DANA CERMINARA to Treatment Outcome
This is a "connection" page, showing publications DANA CERMINARA has written about Treatment Outcome.
Connection Strength
0.037
-
A phase 2 trial of short-term intravenous N-acetylcysteine in biliary atresia after Kasai portoenterostomy. Hepatol Commun. 2025 Jul 01; 9(7).
Score: 0.019
-
Incidence and risk factors for chronic rejection in pediatric liver transplantation. Liver Transpl. 2025 May 01; 31(5):658-667.
Score: 0.018